SCHEMBL8752123

SCHEMBL8752123

Nc1ccccc1Oc1cccc(Oc2ccccc2N)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.50
▸ KDM4E B2RXH2 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ RCE1 Q9Y256 1/20 0.50
▸ CRHBP P24387 1/20 0.50
▸ CRHR2 Q13324 1/20 0.50
▸ IKBKB O14920 2/20 0.47
▸ BRAF P15056 1/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ ADRA2B P18089 1/20 0.46
▸ PTGS1 P23219 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ F2 P00734 2/20 0.44
▸ F10 P00742 2/20 0.44
▸ MAP4K4 O95819 3/20 0.41
▸ IDO1 P14902 1/20 0.41
▸ TLR4 O00206 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7874577 0.79 KDM4E (0.56) GAAKDM4EMAPTRCE1CRHBP
SCHEMBL30979203 0.78 KDM4E (0.65) GAAKDM4EMAPTRCE1CRHBP
SCHEMBL29508342 0.78 KDM4E (0.65) GAAKDM4EMAPTRCE1CRHBP
SCHEMBL81185 0.78 KDM4E (0.65) GAAKDM4EMAPTRCE1CRHBP
SCHEMBL28848008 0.77 MAPT (0.54) GAAKDM4EMAPTRCE1CRHBP
SCHEMBL6289306 0.76 KDM4E (0.62) GAAKDM4EMAPTRCE1CRHBP
SCHEMBL1361220 0.76 KDM4E (0.62) GAAKDM4EMAPTRCE1CRHBP
SCHEMBL1271684 0.76 KDM4E (0.62) GAAKDM4EMAPTRCE1CRHBP
SCHEMBL6293125 0.76 KDM4E (0.62) GAAKDM4EMAPTRCE1CRHBP
Hydrochloric Acid SCHEMBL11737056 0.76 KDM4E (0.62) GAAKDM4EMAPTRCE1CRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0282658-B1 2,6-BIS (AMINOPHENOXY) PYRIDINE AND METHOD OF PREPARING THE SAME MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-09-19 — — EP claimed
US-10023540-B2 Hydrogen barrier agent, hydrogen barrier film forming composition, hydrogen barrier film, method for producing hydrogen barrier film, and electronic element TOKYO OHKA KOGYO CO., LTD. (JP) 2018-07-17 — — US disclosed
US-9981914-B2 — — 2018-05-29 — — US disclosed
US-20180086717-A1 HYDROGEN BARRIER AGENT, HYDROGEN BARRIER FILM FORMING COMPOSITION, HYDROGEN BARRIER FILM, METHOD FOR PRODUCING HYDROGEN BARRIER FILM, AND ELECTRONIC ELEMENT TOKYO OHKA KOGYO CO., LTD. (JP) 2018-03-29 — — US disclosed
EP-0559667-B1 THERMOPLASTICALLY PROCESSABLE AROMATIC POLYETHER AMIDE HOECHST AG (DE) 1997-04-09 — — EP disclosed
US-5549965-A MOLECULAR WEIGHT CONTROLLED BY NON-STOICHIOMETRIC ADDITION OF MONOMER UNITS; ENDS BLOCKED HOECHST AKTIENGESELLSCHAFT (DE) 1996-08-27 — — US disclosed
EP-0496313-B1 Non-woven reinforced with a meltbinder HOECHST AG (DE) 1996-07-17 — — EP disclosed
EP-0496317-B1 Prepreg and fibre reinforced composites therefrom HOECHST AG (DE) 1996-04-10 — — EP disclosed
US-5422397-A Molding materials, solvent resistance HOECHST AKTIENGESELLSCHAFT (DE) 1995-06-06 — — US disclosed
US-5393601-A Aromatic polyamide fibers; high strength filters, reinforcing materials HOECHST AKTIENGESELLSCHAFT (DE) 1995-02-28 — — US disclosed
WO-1992016564-A1 BINARY ALLOYS ON THE BASIS OF POLYETHER AMIDES AND CYCLOOLEFIN POLYMERS HOECHST AKTIENGESELLSCHAFT (DE) 1992-10-01 — — WO disclosed
EP-0496313-A1 Non-woven reinforced with a meltbinder HOECHST AKTIENGESELLSCHAFT (DE) 1992-07-29 — — EP disclosed
EP-0496317-A2 Prepreg and fibre reinforced composites therefrom HOECHST AKTIENGESELLSCHAFT (DE) 1992-07-29 — — EP disclosed
EP-0282658-B1 2,6-BIS (AMINOPHENOXY) PYRIDINE AND METHOD OF PREPARING THE SAME MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-09-19 — — EP disclosed
EP-0282658-A1 2,6-Bis (aminophenoxy) pyridine and method of preparing the same MITSUI TOATSU CHEMICALS, Inc. (JP) 1988-09-21 — — EP disclosed
US-4769463-A POLYIMIDES MITSUI TOATSU CHEMICALS, INC. (JP) 1988-09-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180086717-A1 HYDROGEN BARRIER AGENT, HYDROGEN BARRIER FILM FORMING COMPOSITION, HYDROGEN BARRIER FILM, METHOD FOR PRODUCING HYDROGEN BARRIER FILM, AND ELECTRONIC ELEMENT SLC9A2, SLC9A1, NHERF1 GAA 4606/4885KDM4E 4167/4885MAPT 2522/4885
US-10023540-B2 Hydrogen barrier agent, hydrogen barrier film forming composition, hydrogen barrier film, method for producing hydrogen barrier film, and electronic element SLC9A2, SLC9A1, NHERF1 GAA 4606/4885KDM4E 4167/4885MAPT 2522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback